PANACEABIO.NSPANACEABIO.NSNSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +8.63% | -2.88% | +44.05% | -4.22% | +1.04% |
| Gross Profit Growth | +177.16% | +103.83% | +222.22% | -21.09% | -52.17% |
| EBITDA Growth | +72.68% | +25.43% | +0.00% | -160.26% | -18.19% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -390.00% | -11.95% |
| EPS Growth | +0.00% | +0.00% | +0.00% | -394.81% | -12.16% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | -394.81% | -12.16% |
| Weighted Average Shares Growth | -0.88% | -0.25% | +0.59% | -1.63% | +0.28% |
| Weighted Average Shares Diluted Growth | -0.88% | -0.25% | +0.59% | -1.63% | +0.28% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +37.05% | +0.00% | +18.05% | +0.00% |
| Inventory Growth | +0.00% | +20.08% | +0.00% | +17.09% | +0.00% |
| Asset Growth | +0.00% | +3.96% | +0.00% | +0.92% | +0.00% |
| Book Value per Share Growth | -0.84% | -0.61% | -1.49% | +0.86% | +0.00% |
| Debt Growth | +0.00% | +5.81% | +0.00% | +6.17% | +0.00% |
| R&D Expense Growth | +0.00% | -0.12% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -100.00% | +9.55% | -100.00% | +0.00% | +0.00% |